newsfilter
← Latest News
PR Newswire·

Provention Bio to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022

RED BANK, N.J., Feb. 17, 2022 /PRNewswire/ -- Provention Bio, Inc. (NASDAQ:PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its fourth quarter and full year 2021 fin